Physiological insights and clinical evidence of high flow nasal cannula as first-line therapy for acute hypercapnic exacerbation of COPD: a narrative review
Physiological insights and clinical evidence of high flow nasal cannula as first-line therapy for acute hypercapnic exacerbation of COPD: a narrative review. // Respiratory Medicine and Research. – URL: https://www.sciencedirect.com/science/article/pii/S2590041226000887?dgcid=rss_sd_all
Physiological insights and clinical evidence of high flow nasal cannula as first-line therapy for acute hypercapnic exacerbation of COPD: a narrative review. Respiratory Medicine and Research. https://www.sciencedirect.com/science/article/pii/S2590041226000887?dgcid=rss_sd_all
“Physiological insights and clinical evidence of high flow nasal cannula as first-line therapy for acute hypercapnic exacerbation of COPD: a narrative review.” Respiratory Medicine and Research.
@article{article64240,
title = {Physiological insights and clinical evidence of high flow nasal cannula as first-line therapy for acute hypercapnic exacerbation of COPD: a narrative review},
journal = {Respiratory Medicine and Research},
url = {https://www.sciencedirect.com/science/article/pii/S2590041226000887?dgcid=rss_sd_all}
}